Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa: A Prospective Observational Cohort Study

Condition:   HIV-1-infection Intervention:   Other: This is an observational study only. Sponsors:   Massachusetts General Hospital;   Africa Health Research Institute;   Mbarara University of Science and Technology;   National Institute of Allergy and Infectious Diseases (NIAID);   Wellcome Trust;   ViiV Healthcare;   Harvard Medical School;   University of KwaZulu;   E mory University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials